Lytix Biopharma AS – Mandatory notification of trade by Primary Insiders and close associates
Oslo, Norway, 26 April 2024: Reference is made to the stock exchange announcement published by Lytix Biopharma AS ("Lytix" or the "Company") earlier today, on 26 April 2024, regarding a share issue of 486,377 shares (the "Offer Shares") pursuant to a board autorisation granted by the Company's extraordinary general meeting on 25 April 2024. As of this date, the Company has been informed that the following close associates to primary insiders have been allocated Offer Shares, as set out below: Hifo Invest AS, a close associate to primary insider, Brynjar Forbergsskog,